[HTML][HTML] Non-invasive measurement of hepatic fibrosis by transient elastography: a narrative review

L Rinaldi, C Giorgione, A Mormone, F Esposito… - Viruses, 2023 - mdpi.com
Transient elastography by FibroScan®(Echosens, Paris, France) is a non-invasive method
that can provide a reliable measurement of liver fibrosis through the evaluation of liver …

Cancer risks in solid organ transplant recipients: results from a comprehensive analysis of 72 cohort studies

Z Huo, C Li, X Xu, F Ge, R Wang, Y Wen, H Peng… - …, 2020 - Taylor & Francis
Understanding the cancer risks in different transplant recipients helps early detection,
evaluation, and treatment of post-transplant malignancies. Therefore, we performed a meta …

De novo malignancy after liver transplantation: risk assessment, prevention, and management—guidelines from the ILTS-SETH consensus conference

J Colmenero, P Tabrizian, P Bhangui, DJ Pinato… - …, 2022 - journals.lww.com
De novo malignancies (DNMs) following liver transplantation (LT) have been reported as 1
of the major causes of late mortality, being the most common cause of death in the second …

Colorectal cancer in ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a systematic review and pooled analysis of oncological outcomes

R Angelico, L Siragusa, F Blasi, V Bellato, M Mineccia… - Discover Oncology, 2024 - Springer
Introduction Patients with ulcerative colitis (UC) receiving liver transplantation (LT) due to
primary sclerosing cholangitis (PSC) have higher risk of develo** colorectal cancers …

PD-1 blockade in a liver transplant recipient with microsatellite unstable metastatic colorectal cancer and hepatic impairment

JA Chen, N Esteghamat, EJ Kim, G Garcia… - Journal of the National …, 2019 - jnccn.org
Immune checkpoint inhibitors represent a newly established standard of care in patients with
refractory metastatic colorectal cancer with mismatch repair deficiency and microsatellite …

[HTML][HTML] Management of autoimmune liver diseases after liver transplantation

R Barba Bernal, E Medina-Morales, D Goyes… - Transplantology, 2021 - mdpi.com
Autoimmune liver diseases are characterized by immune-mediated inflammation and
eventual destruction of the hepatocytes and the biliary epithelial cells. They can progress to …

[HTML][HTML] Surveillance and management of de novo malignancy after liver transplantation

WH Kang - Annals of Liver Transplantation, 2024 - synapse.koreamed.org
Liver transplantation (LT) has significantly improved long-term survival rates, but recipients
face increased risks of de novo malignancy (DNM) due to immunosuppression. DNM …

Surgical management of colon cancer in ulcerative colitis patients with orthotopic liver transplant for primary sclerosing cholangitis. A systematic review

GS Sica, B Sensi, L Siragusa, F Blasi, B Crispino… - European Journal of …, 2023 - Elsevier
Introduction Colon cancer in ulcerative colitis patients with liver transplant (UCCOLT) due to
primary sclerosing cholangitis carries significant treatment challenges. Aim of this literature …

[HTML][HTML] A reduction of Calcineurin inhibitors may improve survival in patients with De novo colorectal Cancer after liver transplantation

RR Ossami Saidy, E Wegener, D Uluk, L Dittrich… - Medicina, 2022 - mdpi.com
Background and Objectives: After liver transplantation (LT), long-term immunosuppression
(IS) is essential. IS is associated with de novo malignancies, and the incidence of colorectal …

Characteristics and prognosis of colorectal cancer after liver or kidney transplantation

M Kim, CW Kim, S Hwang, YH Kim, JL Lee… - World journal of …, 2021 - Springer
Background The purpose of this study was to evaluate the characteristics and prognosis of
de novo CRC patients who underwent liver or kidney transplantation. Methods We …